Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Takeda Pharmaceutical CO LTD Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

$3.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 29, 2019	SELL	$16.15 - $17.99 $910,876 - $1.01 Million	-56,401 Closed	0 $0
Q2 2019 Jul 17, 2019	SELL	$16.58 - $20.49 $689,131 - $851,646	-41,564 Reduced 42.43%	56,401 $993,000
Q1 2019 Apr 29, 2019	BUY	$16.7 - $21.52 $1.64 Million - $2.11 Million	97,965 New	97,965 $2.02 Million

Others Institutions Holding TAK

# of Institutions

337

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

Capital Research Global Investors Los Angeles, CA

13.1M
Shares

$178 Million
0.04% of portfolio
Morgan Stanley New York, NY

5.35M
Shares

$72.6 Million
0.01% of portfolio
Mondrian Investment Partners LTD London, X0

5.09M
Shares

$69.1 Million
1.21% of portfolio
Arrowstreet Capital, Limited Partnership Boston, MA

4.64M
Shares

$62.9 Million
0.05% of portfolio
Goldman Sachs Group Inc New York, NY

4.56M
Shares

$61.8 Million
0.01% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Account